4//SEC Filing
Dorsey Brian 4
Accession 0001415889-24-021886
CIK 0001671858other
Filed
Aug 20, 8:00 PM ET
Accepted
Aug 21, 6:51 PM ET
Size
8.6 KB
Accession
0001415889-24-021886
Insider Transaction Report
Form 4
Dorsey Brian
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2024-08-20$0.64/sh+50,000$32,000→ 56,024 total - Sale
Common Stock
2024-08-20$15.00/sh−50,000$750,000→ 6,024 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-08-20−50,000→ 61,828 totalExercise: $0.64Exp: 2028-11-28→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2023.
- [F2]Immediately exercisable.
Documents
Issuer
ARS Pharmaceuticals, Inc.
CIK 0001671858
Entity typeother
Related Parties
1- filerCIK 0001380762
Filing Metadata
- Form type
- 4
- Filed
- Aug 20, 8:00 PM ET
- Accepted
- Aug 21, 6:51 PM ET
- Size
- 8.6 KB